Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Some drugs such as bleomycin or doxycycline, or other compounds like talc, may
help to control fluid in the chest caused by cancer. It is not yet known if bleomycin,
doxycycline, or talc is more effective in treating patients with malignant pleural effusions.
PURPOSE: Randomized phase III trial to compare the effectiveness of bleomycin, doxycycline,
or talc in treating patients with malignant pleural effusions.
Phase:
Phase 3
Details
Lead Sponsor:
Eastern Cooperative Oncology Group
Collaborators:
National Cancer Institute (NCI) North Central Cancer Treatment Group